Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Short term Debt (2017 - 2025)

Bioceres Crop Solutions' Short term Debt history spans 6 years, with the latest figure at $119.7 million for Q2 2025.

  • For Q2 2025, Short term Debt fell 12.45% year-over-year to $119.7 million; the TTM value through Jun 2025 reached $119.7 million, down 12.45%, while the annual FY2025 figure was $119.7 million, 12.45% down from the prior year.
  • Short term Debt for Q2 2025 was $119.7 million at Bioceres Crop Solutions, down from $136.7 million in the prior quarter.
  • Across five years, Short term Debt topped out at $136.7 million in Q2 2024 and bottomed at $25.9 million in Q4 2021.
  • The 4-year median for Short term Debt is $107.6 million (2023), against an average of $93.4 million.
  • The largest annual shift saw Short term Debt increased 27.04% in 2024 before it dropped 12.45% in 2025.
  • A 4-year view of Short term Debt shows it stood at $25.9 million in 2021, then skyrocketed by 315.45% to $107.6 million in 2023, then rose by 27.04% to $136.7 million in 2024, then dropped by 12.45% to $119.7 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Short term Debt are $119.7 million (Q2 2025), $136.7 million (Q2 2024), and $107.6 million (Q2 2023).